Equity Investees (Tables)

9 Months Ended

Sep. 30, 2016

Equity Method Investments and Joint Ventures [Abstract]

Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Genesis’ share of operating earnings	$	16,444		$	17,944		$	47,281		$	57,607
Amortization of excess purchase price	(3,956		)	(3,684		)	(11,919		)	(9,167		)
Net equity in earnings	$	12,488		$	14,260		$	35,362		$	48,440
Distributions received	$	21,551		$	23,522		$	66,180		$	73,823

Schedule Of Balance Sheet Information For Equity Investees

The following tables present the unaudited balance sheet and income statement information (on a 100% basis) for Poseidon (which is our most significant equity investment):

	September 30, 2016		December 31, 2015
BALANCE SHEET DATA:
Assets
Current assets	$	14,662	$	18,507
Fixed assets, net	236,509		248,059
Other assets	929		1,133
Total assets	$	252,100	$	267,699
Liabilities and equity
Current liabilities	$	23,135	$	22,456
Other liabilities	211,066		203,514
Equity	17,899		41,729
Total liabilities and equity	$	252,100	$	267,699

Schedule Of Operations For Equity Investees

	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
INCOME STATEMENT DATA:
Revenues	$	31,219	$	30,830	$	90,658	$	92,684
Operating income	$	23,107	$	23,839	$	68,166	$	71,122
Net income	$	21,921	$	22,860	$	64,670	$	67,804